June 29, 2026 · Form 4 insider transaction
Pauls Matthew bought 6,000 shares of Palvella Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The options vest in 36 equal monthly installments, subject to the Reporting Person's continued service as of each such vesting date.